Pharma-Bio Serv (PBSV) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -18.09% |
| Oct 31, 2025 | -23.55% |
| Jul 31, 2025 | -18.98% |
| Apr 30, 2025 | -16.40% |
| Jan 31, 2025 | -16.78% |
| Oct 31, 2024 | -18.75% |
| Jul 31, 2024 | -25.05% |
| Apr 30, 2024 | -21.59% |
| Jan 31, 2024 | -23.99% |
| Oct 31, 2023 | -16.04% |
| Jul 31, 2023 | -8.60% |
| Apr 30, 2023 | 114.84% |
| Jan 31, 2023 | 16.36% |
| Oct 31, 2022 | 6.21% |
| Jul 31, 2022 | 31.30% |
| Apr 30, 2022 | 23.43% |
| Jan 31, 2022 | 23.96% |
| Oct 31, 2021 | -60.55% |
| Jul 31, 2021 | 37.89% |
| Apr 30, 2021 | 22.85% |
| Jan 31, 2021 | -3.64% |
| Oct 31, 2020 | -23.14% |
| Jul 31, 2020 | 10.52% |
| Apr 30, 2018 | -14.93% |
| Jan 31, 2018 | -31.39% |
| Oct 31, 2017 | -38.08% |
| Jul 31, 2017 | -16.25% |
| Apr 30, 2017 | -17.37% |
| Jan 31, 2017 | -17.94% |
| Oct 31, 2016 | -19.50% |
| Jul 31, 2016 | -16.03% |
| Apr 30, 2016 | -33.66% |
| Jan 31, 2016 | -5.79% |
| Oct 31, 2015 | 15.30% |
| Jul 31, 2015 | 19.32% |